SUMMARY Experiments on dogs and rats showed that synthetic human gastrin I was inactivated in the small bowel but not in the liver, whereas pentagastrin was rapidly inactivated by the liver. Similar results were obtained with tissue homogenates. The significance of these results is discussed in relation to the probably increased incidence of peptic ulceration following extensive small-bowel resection in man.
The physiological and pharmacological actions of the hormone gastrin and of its synthetic analogue pentagastrin1 have been extensively studied. Gastrin may be involved in the causation ofpeptic ulceration, and pentagastrin is now widely used as a gastric stimulant in tests of acid secretion, but little is known of the fate of either compound in the body. Since the blood concentration of a hormone or a drug depends on its rate of removal from the circulation as well as the rate at which it enters the circulation, it is important to study the fate of active substances in the body. For example, excessive levels of gastrin might be present in the blood even though the antrum secreted normal amounts; this could occur if the mechanism for removing gastrin were impaired. We have therefore devised experiments to investigate the inactivation of gastrin and pentagastrin by the liver and small bowel. In choosing to study the fate of these compounds in the portal circulation we were guided by the concept originally proposed by Elliott (1905) that hormones disappear in the tissues they excite. The experiments were performed on anaesthetized dogs and rats, and in vitro with homogenates of rat liver and small bowel mucosa.
Methods

EXPERIMENTS IN DOGS
Ten adult mongrel dogs weighing 6-16 kg were anaesthetized with intravenous pentobarbitone (25 mg/kg body weight), and mechanically respired. In all the dogs wide bore cannulae were placed in the 1Peptavlon, ICI Ltd.
Received for publication 16 March 1971. pyloric antrum and the fundus of the stomach. Ligatures were tied around the pylorus and the oesophagus, care being taken in the latter case to exclude the vagi. During experiments the dog lay on its left side and the cannulae were placed so that fluid introduced into the pyloric cannula drained by gravity through the stomach and was all recovered from the fundal cannula. Fine Acid secretion was measured for 40 minutes before commencing infusions, and during the infusions by washing out the stomach every 10 minutes with 20 ml of 015M sodium chloride solution. Five ml of each collection was titrated to pH 7 with 0.1N NaOH using a Radiometer autotitrator and pH meter.
EXPERIMENTS IN RATS
Acid secretion in response to standard doses (50, 100, or 150 ng) of either gastrin or pentagastrin was measured in 36 anaesthetized rats according to the technique described by Smith, Lawrence, ColinJones, and Schild (1970) , except that during the preparation of the animals loose ligatures were placed round the superior mesenteric vessels. The basic technique involves the recirculation of 1.67 mM succinate-propionate buffer, pH 5-6, through the rat stomach and monitoring the pH change occurring in the buffer following injections of secretagogues via the jugular vein. Each animal received two of the standard doses, and acid secretion in response to each was measured. In half the rats, the ligatures were then tied, thus excluding the small bowel from the circulation; in the remaining rats the ligatures were left loose. The two standard doses of gastrin or pentagastrin previously given were then repeated in the same order, and the acid secretory responses were measured again.
EXPERIMENTS in vitro
Rats were killed by cervical dislocation and homogenates were prepared from the liver and the small bowel mucosa as follows. The tissue was homogenized in 5 volumes of 0.25M sucrose using a Potter-Elvejhem homogenizer. Large particles were deposited and discarded by centrifuging twice at 1800 g for 10 min; smaller particles were discarded after centrifuging at 105,000 g for 60 minutes. The protein content of each homogenate was measured by the method of Lowry, Rosebrough, Farr, and Randall (1951) using crystalline bovine plasma albumen as standard.
To study the actions of homogenates on gastrin and pentagastrin, homogenate (diluted 10 times in some experiments) was incubated with gastrin or pentagastrin to give a final substrate concentration of 0.67 n mol/ml (1.5 ,ug/ml for gastrin, 05 (Smith et al, 1970) .
Results
ACID SECRETION IN DOGS
In all dogs infusion of gastrin or pentagastrin produced an increase in acid secretion to more than 10 times the basal level. Typical experiments are shown in Figures 1 and 2 . In the experiment shown in Fig. 1 is reduced by transit through the small bowel vascular bed.
ACID SECRETION IN RATS
In groups of six rats the mean acid secretory responses to 50 ng, 100 ng, or 150 ng of gastrin or pentagastrin were compared before and after ligation of the superior mesenteric vessels. Similar experiments were performed on control animals, in which the ligatures were not tied between responses. The results (Table II) show that there was no significant difference between responses in any of the control groups, or between responses to pentagastrin before and after ligation of the superior mesenteric vessels. In contrast, a significant rise in acid secretion occurred after mesenteric ligation in response to all three doses of gastrin. These results support the findings in the experiments on dogs with regard to gastrin and show that pentagastrin is not inactivated by the small bowel in the rat.
EXPERIMENTS in vitro
The rates of inactivation of pentagastrin and gastrin by homogenates of rat liver and small bowel mucosa are shown in Table III 
Discussion
The results of the experiments on dogs indicate that the biological activity of synthetic human gastrin I is unaffected by transit through the liver. They are in keeping with the results of Gillespie and Grossman (1962) , Clarke, Hall, Devor, and Rizer (1967) , Lick, Welsch, Hart, Bruckner, Balser, and Gurtner (1967) and McGuigan, Jaffe, and Newton (1970) . Thompson, Reeder, Davidson, Charters, Bruckner, Lemmi, and Miller (1969) Cole, and Thum (1966) have reported that extensive small bowel resection in man is followed by excessive acid secretion and a high incidence of peptic ulceration, which in some patients has proved fatal. They suggested that the small bowel produced an inhibitor of acid secretion, and that loss of this inhibitor after small bowel resection was the cause of the gastric hypersecretion. Our results cannot be interpreted in this way and they lead to the simpler explanation that gastrin is inactivated in the small bowel. Pentagastrin is not affected by the small bowel, at least in rats but it is rapidly inactivated by the liver. The experiments in vitro support these observations and show that small-bowel homogenates rapidly inactivate gastrin but have no effect on pentagastrin, whereas liver homogenates inactivate pentagastrin very much more rapidly than gastrin. This means that the different potencies of gastrin and pentagastrin may be explained by their relative rates of metabolism and not by any intrinsic difference in their effects on the parietal cells.
It is evident that there are different enzymes in homogenates of liver and small-bowel mucosa which inactivate pentagastrin and gastrin respectively. Pentagstrin and gastrin have the same C-terminal tetrapeptide sequence in which all their biological activity appears to reside (Morley, Tracy, and Gregory, 1965) . The biologically inactive part of the gastrin molecule (residues 1-13) is not, however, without function. Our experiments indicate that it protects the molecule from inactivation in the liver. Furthermore, it allows inactivation of gastrin in the small bowel and our experiments suggest that a specific enzyme exists in the small bowel to do this.
